莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300006 莱美药业

交易中 08-16 09:30:27

{"stockData":{"symbol":"300006","market":"SZ","secType":"STK","nameCN":"莱美药业","latestPrice":2.63,"timestamp":1723771827000,"preClose":2.62,"halted":0,"volume":317000,"delay":0,"floatShares":1056000000,"shares":1056000000,"eps":-0.0094,"marketStatus":"交易中","marketStatusCode":2,"change":0.01,"latestTime":"08-16 09:30:27","open":2.65,"high":2.65,"low":2.62,"amount":837700,"amplitude":0.0115,"askPrice":2.64,"askSize":814,"bidPrice":2.62,"bidSize":1383,"shortable":0,"etf":0,"ttmEps":-0.0094,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1723779000000},"adr":0,"adjPreClose":2.62,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":2.88,"lowLimit":2.36,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1055911205,"pbRate":1.33,"roa":"--","roe":"--","epsLYR":-0.0085,"committee":0.471964,"marketValue":2777000000,"floatMarketCap":2777000000,"peRate":-279.787238,"changeRate":0.0038,"turnoverRate":0.0003,"status":0},"requestUrl":"/m/hq/s/300006","defaultTab":"news","newsList":[{"id":"2457333892","title":"知识产权保护概念盘中拉升，莱美药业涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457333892","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457333892?lang=zh_cn&edition=full","pubTime":"2024-08-08 10:34","pubTimestamp":1723084478,"startTime":"0","endTime":"0","summary":"08月08日，知识产权保护概念盘中拉升，截至10点34分，知识产权保护概念整体指数上涨0.55%，报895.230点。从个股上来看，该概念的成分股中，莱美药业涨5.14%，祥源文旅、华媒控股、安妮股份涨幅居前。从资金上来看，截止发稿，知识产权保护概念主力净流入为-2.46亿，其中祥源文旅受到资金热捧，主力净流入380.20万；拉长时间线来看，该板块近20日主力资金净流入-26.01亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808103438aefdd532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808103438aefdd532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0211","BK0028","BK0102","BK0004","BK0098","600576","BK0083","BK0149","BK0239","BK0228","BK0095","BK0070","BK0012","300006"],"gpt_icon":0},{"id":"2456408698","title":"莱美药业最新公告：公司及子公司诉讼事项二审终审判决结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2456408698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456408698?lang=zh_cn&edition=full","pubTime":"2024-08-02 18:11","pubTimestamp":1722593483,"startTime":"0","endTime":"0","summary":"莱美药业公告，公司及子公司莱美医药与海悦药业因《他达拉非片中国区授权协议》纠纷案，近日收到长春市中院二审终审判决。判决结果显示，莱美医药需支付海悦药业销售款21,648,313元，公司对莱美医药的支付义务承担连带赔偿责任。经财务初步测算，本次诉讼预计影响公司本期利润总额的金额约为2969万元。公司将决定是否就二审判决申请再审，并及时履行信息披露义务。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080200039512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0239","BK0070"],"gpt_icon":0},{"id":"2453807081","title":"莱美药业：公司纳米炭混悬注射液出海工作正在稳步推进中，将力争按原定计划完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2453807081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453807081?lang=zh_cn&edition=full","pubTime":"2024-07-23 18:01","pubTimestamp":1721728880,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业07月23日在投资者关系平台上答复投资者关心的问题。目前公司暂无上述相关计划，您的建议我们将予以转达。公司纳米炭混悬注射液出海工作正在稳步推进中，将力争按原定计划完成。目前公司控股子公司瀛瑞医药纳米炭铁临床一期工作正在稳步推进过程中，公司将根据具体临床进展情况按照交易所相关规则履行相应公告义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300034687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"gpt_icon":0},{"id":"2450336519","title":"莱美药业：公司前十大股东无出借股份情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2450336519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450336519?lang=zh_cn&edition=full","pubTime":"2024-07-11 17:03","pubTimestamp":1720688612,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业07月11日在投资者关系平台上答复投资者关心的问题。公司前十大股东无出借股份情况。公司将严格按照深交所规定履行信息披露义务，请关注公司相关公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100033478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"gpt_icon":0},{"id":"2449797523","title":"莱美药业（300006）7月5日主力资金净买入544.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449797523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449797523?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:11","pubTimestamp":1720401114,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月5日收盘，莱美药业报收于2.44元，上涨6.09%，换手率1.5%，成交量15.8万手，成交额3774.24万元。近5日资金流向一览见下表：莱美药业融资融券信息显示，融资方面，当日融资买入336.9万元，融资偿还199.06万元，融资净买入137.84万元。融券方面，融券卖出3.4万股，融券偿还9300.0股，融券余量14.81万股，融券余额36.14万元。莱美药业主营业务：医药制造。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800001866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"gpt_icon":0},{"id":"2441228801","title":"莱美药业(300006.SZ)：邱宇和中恒集团签署《表决权委托协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2441228801","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441228801?lang=zh_cn&edition=full","pubTime":"2024-06-05 17:06","pubTimestamp":1717578401,"startTime":"0","endTime":"0","summary":"格隆汇6月5日丨莱美药业(300006.SZ)公布，股东邱宇先生于2023年4月7日与控股股东广西梧州中恒集团股份有限公司（简称“中恒集团”）签署了《之补充协议》，该协议将于2024年6月7日到期。2024年6月4日，邱宇先生和中恒集团签署了《表决权委托协议》，本次表决权委托期限至2026年6月7日。本次协议的签署不会导致上市公司控制权发生变更，亦未触发《上市公司收购管理办法》规定的要约收购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406051707589590a38d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406051707589590a38d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300006","BK0012","BK0077","BK0015","BK0028","BK0239","BK0188","BK0070","600252"],"gpt_icon":0},{"id":"2440400891","title":"中恒集团(600252.SH)子公司莱美药业收到盐酸纳洛酮注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2440400891","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440400891?lang=zh_cn&edition=full","pubTime":"2024-06-04 17:54","pubTimestamp":1717494889,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中恒集团(600252.SH)发布公告，公司控股子公司重庆莱美药业股份有限公司(简称“莱美药业”)收到国家药品监督管理局核准签发的规格为1ml:0.4mg的盐酸纳洛酮注射液《药品注册证书》，盐酸纳洛酮注射液为阿片类受体拮抗药，用于阿片类药物复合麻醉术后，拮抗该类药物所致的呼吸抑制，促使病人苏醒;用于阿片类药物过量，完全或部分逆转阿片类药物引起的呼吸抑制;用于解救急性乙醇中毒;用于急性阿片类药物过量的诊断。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1130844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","600252","BK0015","300006","BK0070","BK0239","BK0188","BK0012","BK0077"],"gpt_icon":0},{"id":"2440008674","title":"【中恒集团(600252.SH)子公司莱美药业收到盐酸纳洛酮注射液药品注册证书】智通财经APP讯，中恒集团(600252.","url":"https://stock-news.laohu8.com/highlight/detail?id=2440008674","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440008674?lang=zh_cn&edition=full","pubTime":"2024-06-04 17:54","pubTimestamp":1717494889,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0012","300006","BK0028","BK0015","600252","BK0077","BK0239","BK0070","BK0188"],"gpt_icon":0},{"id":"2440407280","title":"中恒集团：子公司获盐酸纳洛酮注射液药品注册证书中恒集团公告，控股子公司莱美药业收到国家药品监督管理局核准签发的规格为1ml:0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2440407280","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440407280?lang=zh_cn&edition=full","pubTime":"2024-06-04 17:46","pubTimestamp":1717494416,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","BK0070","BK0015","600252","300006","BK0028","BK0188","BK0012","BK0077"],"gpt_icon":0},{"id":"2440840100","title":"【莱美药业(300006.SZ)：盐酸纳洛酮注射液获药品注册证书】智通财经APP讯，莱美药业(300006.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的规格为1ml:0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2440840100","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440840100?lang=zh_cn&edition=full","pubTime":"2024-06-04 17:04","pubTimestamp":1717491882,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0070","300006","BK0239"],"gpt_icon":0},{"id":"2440401049","title":"莱美药业(300006.SZ)：盐酸纳洛酮注射液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2440401049","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440401049?lang=zh_cn&edition=full","pubTime":"2024-06-04 17:04","pubTimestamp":1717491882,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的规格为1ml:0.4mg的盐酸纳洛酮注射液《药品注册证书》。据悉，盐酸纳洛酮注射液由美国ADAPT制药公司研发，目前在美国和日本均有上市，尚未进口国内。盐酸纳洛酮注射液为阿片类受体拮抗药，用于阿片类药物复合麻醉术后，拮抗该类药物所致的呼吸抑制，促使病人苏醒;用于阿片类药物过量，完全或部分逆转阿片类药物引起的呼吸抑制;用于解救急性乙醇中毒;用于急性阿片类药物过量的诊断。本次公司取得盐酸纳洛酮注射液(1ml:0.4mg)《药品注册证书》，有利于进一步丰富公司产品线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1130756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0070","300006"],"gpt_icon":0},{"id":"2430492824","title":"莱美药业（300006）2024年一季报简析：净利润减25.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430492824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2430492824?lang=zh_cn&edition=full","pubTime":"2024-04-25 06:12","pubTimestamp":1713996744,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期莱美药业发布2024年一季报。根据财报显示，本报告期中莱美药业净利润减25.9%。截至本报告期末，公司营业总收入1.81亿元，同比下降20.09%，归母净利润-457.53万元，同比下降25.9%。其中，毛利率64.82%，同比减8.43%，净利率0.02%，同比增100.52%，销售费用、管理费用、财务费用总计1.13亿元，三费占营收比62.26%，同比减6.82%，每股净资产1.97元，同比减2.21%，每股经营性现金流0.07元，同比增725.99%，每股收益-0.0元，同比减26.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500011900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006"],"gpt_icon":0},{"id":"2429161464","title":"莱美药业最新公告：一季度净亏损457.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429161464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429161464?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:01","pubTimestamp":1713866476,"startTime":"0","endTime":"0","summary":"莱美药业公布2024年一季度报告，报告期营业收入1.81亿元，同比下降20.09%；归属于上市公司股东的净利润亏损457.53万元。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300035359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0070"],"gpt_icon":0},{"id":"2429166919","title":"莱美药业(300006.SZ)发布一季度业绩，净亏损457.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429166919","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429166919?lang=zh_cn&edition=full","pubTime":"2024-04-23 17:24","pubTimestamp":1713864252,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)发布2024年第一季度报告，该公司营业收入为1.81亿元，同比减少20.09%。归属于上市公司股东的净亏损为457.53万元，同比扩大。归属于上市公司股东的扣除非经常性损益的净亏损为743.37万元，同比收窄。基本每股亏损为0.0043元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300006","BK0239","BK0070"],"gpt_icon":0},{"id":"2427810246","title":"莱美药业伏立康唑片和紫杉醇注射液中选十三省联盟药品集采根据《十三省(区、兵团)联盟药品集中带量采购文件》产生中选结果，莱美药业(300006)的伏立康唑片和紫杉醇注射液中选十三省药品联盟集中采购。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427810246","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427810246?lang=zh_cn&edition=full","pubTime":"2024-04-16 16:55","pubTimestamp":1713257728,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300006","BK0070","BK0239"],"gpt_icon":0},{"id":"2422877163","title":"【莱美药业(300006.SZ)：CUD005注射液获准开展治疗失代偿期肝硬化临床试验】智通财经APP讯，莱美药业(300006.","url":"https://stock-news.laohu8.com/highlight/detail?id=2422877163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422877163?lang=zh_cn&edition=full","pubTime":"2024-03-28 18:28","pubTimestamp":1711621709,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","159891","BK0070","BK1583","03347","BK1576","300006","BK0239"],"gpt_icon":0},{"id":"2422560896","title":"【莱美药业(300006.SZ)子公司内窥镜产品获得医疗器械注册证】智通财经APP讯，莱美药业(300006.SZ)发布公告，近日，公司控股子公司海南莱美医疗器械有限公司（以下简称“莱美医疗器械”）收到海南省药品监督管理局颁发的两项《医疗器械注册证》，产品分别为：“械电子内窥镜图像处理器”、“一次性使用电子支气管成像导管”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2422560896","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422560896?lang=zh_cn&edition=full","pubTime":"2024-03-25 16:46","pubTimestamp":1711356390,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09997","09996","BK0070","BK1574","BK0239","159883","BK1100","BK1583","300006","BK1222"],"gpt_icon":0},{"id":"2422758327","title":"莱美药业减亏术","url":"https://stock-news.laohu8.com/highlight/detail?id=2422758327","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422758327?lang=zh_cn&edition=full","pubTime":"2024-03-24 23:35","pubTimestamp":1711294500,"startTime":"0","endTime":"0","summary":"　　莱美药业于3月23日披露2023年年报，公司2023年净利亏损892.73万元，同比大幅减亏。　　2023年前三季度归属净利润亏损逾5400万元的莱美药业，2023年全年亏损出现收窄，仅亏损892.73万元。　　莱美药业2023年年报显示，报告期内，公司实现营业收入约为8.96亿元，同比增长1.24%；对应实现的归属净利润约为-892.73万元，上年同期净利为-6870.52万元，同比大幅减亏；对应实现的扣非后净利润约为-5993.33万元，上年同期为-1.15亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-03-24/doc-inapmyzm0590923.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-03-24/doc-inapmyzm0590923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","300006","BK0239"],"gpt_icon":0},{"id":"2421815818","title":"【莱美药业(300006.SZ)发布2023年度业绩，净亏损892.73万元】智通财经APP讯，莱美药业(300006.SZ)发布2023年年度报告，该公司营业收入为8.","url":"https://stock-news.laohu8.com/highlight/detail?id=2421815818","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421815818?lang=zh_cn&edition=full","pubTime":"2024-03-22 20:47","pubTimestamp":1711111622,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["300006","BK0070","BK0239"],"gpt_icon":0},{"id":"2421100440","title":"【111.82亿元市值限售股今日解禁，中无人机解禁市值31.37亿元居首】 周五，共有14家公司限售股解禁，合计解禁量为6.","url":"https://stock-news.laohu8.com/highlight/detail?id=2421100440","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421100440?lang=zh_cn&edition=full","pubTime":"2024-03-22 07:46","pubTimestamp":1711064804,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["688297","300006","605389","BK0259","BK0239","605286","BK0070","BK0279"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2009-10-30","address":"重庆市南岸区玉马路99号","stockEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.1245},{"period":"3month","weight":-0.0934},{"period":"6month","weight":0.0962},{"period":"1year","weight":-0.2742},{"period":"ytd","weight":-0.2957}],"companyName":"重庆莱美药业股份有限公司","boardCode":"AI0027","perCapita":"33634股","boardName":"医药制造业","registeredCapital":"105591万元","compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0877},{"period":"6month","weight":0.004},{"period":"1year","weight":-0.0866},{"period":"ytd","weight":-0.0328}],"survey":"　　重庆莱美药业股份有限公司的主要业务为医药制造，公司产品品种丰富，结构合理，公司主要产品为化药，涵盖特色专科类（主要包括抗肿瘤药、消化系统药、肠外营养药）、抗感染类等。公司重点品种纳米炭混悬注射液(卡纳琳)，系首款获得CFDA批准的淋巴示踪剂，卡纳琳连续四年获得“中国化学制药行业原研药,专利药优秀产品品牌”,连续两年获得“中国化学制药行业其他各科用药优秀产品品牌”,获得“制造业单项冠军产品(2019-2021年)”,“2021年中国产学研合作创新与促进奖”等多项荣誉称号。","serverTime":1723771830831,"listedPrice":16.5,"stockholders":"31391人(较上一季度减少1.78%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱美药业,300006,莱美药业股票,莱美药业股票老虎,莱美药业股票老虎国际,莱美药业行情,莱美药业股票行情,莱美药业股价,莱美药业股市,莱美药业股票价格,莱美药业股票交易,莱美药业股票购买,莱美药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}